Initial fixed backbone specificity redesign used the computational second site suppressor protocol described previously (1). Flexible backbone specificity redesign employed the sequence tolerance protocol described in (2), using Rosetta revision r33982 and the command lines below.
Soft repulsive fixed backbone design Without ligand:
PATH/TO/ROSETTA/fixbb.EXECUTABLE -database PATH/TO/ROSETTA_DATABASE -s 1ki1.pdb -resfile <RESFILE_NAME> -ex1 -ex2 -ex3 -ex4 -extrachi_cutoff 0 -score:weights soft_rep_design -out:prefix <PREFIX> -nstruct 30 -overwrite -out:pdb_gz
With GDP:
PATH/TO/ROSETTA/fixbb.EXECUTABLE -database PATH/TO/ROSETTA_DATABASE -s <1KI1_WITH_GDP> -resfile <RESFILE_NAME> -ex1 -ex2 -ex3 -ex4 -extrachi_cutoff 0 -score:weights soft_rep_design -out:prefix <PREFIX> -nstruct 30 -overwrite -out:pdb_gz -extra_res_fa <PARAMS_FILE>
The PARAMS_FILE contains instructions for Rosetta on how to handle the ligand, including possible conformation(s). It needs to be specifically generated for each type of ligand. For all simulations reported here, the presence or absence of a GDP ligand in the structure did not lead to significantly different results in terms of backbone RMSD or side chain conformations around the mutated sites (the GDP binding site is distant from the F56R and S1373E mutations, with a distance of 9.9Å between the closest atoms). -pivot_residues determines which residues may be used as pivots by Backrub. This list restricts the pivots to 10Å around the designed residues, using Rosetta's internal residue numbering which is sequential across all chains, starting at 1. 305 306 307 308 309 310 311 312 313 314 324 325 326 327 328 329 330 331 332   333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351   352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370   371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389   390 391 392 393 -exclude_res specifies the residues to be ignored for RMSD calculation -only those in the flexible loops are considered here. This uses Rosetta's internal residue numbering, which is sequential across all chains, starting at 1.
Backrub ensemble generation

Soft repulsive KIC
PATH
Plasmids
All constructs used in this paper are listed in SI Table S4 . All sequence substitutions were made using the QuikChange mutagenesis system (Stratagene). All sequences were verified by DNA sequencing.
Protein expression and purification
Proteins were expressed as His6 fusion proteins in the Rosetta2 strain of E. coli (EMD Biosciences) using a 3 hour induction with IPTG (Isopropyl β-D-1-thiogalactopyranoside). Cells were lysed by sonication, His6 tagged proteins were bound to Ni-NTA resin (Qiagen) and eluted in 50 mM Na 2 HPO 4 /NaH 2 PO 4 , 300 mM NaCl, 250 mM imidazole, pH 8.0. The His6 tag was cleaved by room temperature incubation with a His6-tagged TEV (Tobacco Etch Virus) protease, followed by removal of the protease and free His6 tags using a second Ni-NTA purification. GTPases were further purified using a SourceQ ion exchange column (Amersham).
GTPase concentrations were determined by the Coomassie Plus system (Pierce). Exchange factor concentrations were determined by absorbance at 280nm using extinction coefficients calculated using the method of Pace et al. (3) .
In vitro nucleotide exchange assays
For nucleotide dissociation assays, purified GTPases were loaded with mantGDP (methylanthraniloyl-GDP, Molecular Probes) by incubation with a ten-fold molar excess of mantGDP for 30 minutes at room temperature in a buffer of 20mM Tris pH 7.6, 200mM NaCl, 1mM DTT, and 10mM EDTA. Nucleotide loading was quenched by addition of 10-fold molar excess of MgCl 2 above the EDTA concentration and excess nucleotide was removed using NAP-5 columns (GE Healthcare) equilibrated in Exchange Assay Buffer (20 mM Tris, 50 mM NaCl, 10 mM MgCl 2 , 1% glycerol, 1 mM DTT, pH 7.5). Dissociation of mantGDP from GTPases was measured in a SpectraMax Gemini XS (Molecular Devices) fluorescence multi-well plate reader (25°C, excitation: 360 nm, emission: 440 nm). Solutions were pre-equilibrated at 25°C for 10 minutes, and the reaction was initiated by transferring pre-mixed GEF/GDP to mantGDPbound GTPases. Final concentrations were 1 µM mantGDP-bound GTPase, 1 µM GEF, 200 µM GDP in Exchange Assay Buffer.
For nucleotide association assays, GTPase and GEF were mixed with Exchange Assay Buffer to a final concentration of 0.5 µM for GTPase and varying concentrations of GEF. The solutions were equilibrated for 10 minutes before the addition of mantGDP to a final concentration of 400 nM to start the reaction.
Reaction progress was monitored by fluorescence as above. Rates were determined by linear fits to the initial rates of exchange (4). The fold catalysis was determined by dividing the catalyzed rate by the uncatalyzed rate (for the GTPase alone without GEF).
Circular dichroism (CD) spectroscopy
CD data were collected on each protein (Cdc42 and ITSN, WT and variants) at concentrations close to 10µΜ on an Aviv CD spectrophotometer. CD data collection was done in a buffer of 10 mM sodium phosphate, pH 7.0, and 100 mM NaCl, in a 0.2 cm cuvette. Samples were cooled to 4°C and then heated to 90°C and the ellipticity at 222 nm recorded at 3°C increments. Ellipticity was converted to mean residue ellipticity (MRE).
Surface plasmon resonance
All experiments were performed on a Biacore T100 instrument using a running buffer of HBS-P (0. 
Crystallography
The orthoCdc42 (F56R) and orthoITSN DH/PH (S1373E) proteins were purified using the NiNTA resin and the His6 tags were cleaved and removed as described above. Each protein was then further purified by gel filtration over a Sephacryl S100HR column (Amersham) in a buffer of 50 mM sodium phosphate (pH 7.4) and 150 mM NaCl. Purified proteins were concentrated in a buffer of 20 mM Tris pH 7.5, 150 mM NaCl, 2 mM EDTA, and 1 mM DTT and then combined in a 1:1 molar ratio to a final concentration of 10mg/mL.
X-ray diffraction data were collected on beam 8.3.1 at the Advanced Light Source at Lawrence Berkeley National Laboratory. A single data set was collected from a crystal diffracting to 2.65 Å and processed in space group P21 with HKL2000 (5), phased by molecular replacement using AMORE (6) with 1KI1 as a search model. Rebuilding was performed manually with Coot (7) with iterative refinement using phenix.refine (8) using non-crystallographic symmetry between the two copies of the orthoITSN/orthoCdc42 complex present in the asymmetric unit.
WASP fluorescence titration
WASP fluorescence titrations were performed as described previously (9) . The W13 fragment of WASP(9) (residues 201-321) was cloned into a His6 expression vector, expressed and purified as described in the main Methods for GTPase and GEF proteins, and the His6 tag was cleaved by treatment with TEV protease. The W13 concentration was determined using an extinction coefficient (E 280 ) of 8250 M -1 cm -1 (9) . Purified Cdc42 WT and orthoCdc42 were preloaded with mantGMPPNP (Molecular Probes)
as described in the main Methods for mantGDP. Proteins were diluted in 40 mM HEPES-NaOH pH 7.4, 100 mM NaCl. solution using a Hamilton syringe allowing for 1 minute of mixing before averaging fluorescence emission for 2 seconds. Raw data were corrected for Cdc42 concentration and then fit as described (9) .
GAP assay
GTP hydrolysis by Cdc42 was tested using the EnzChek Phosphate Assay Kit (Invitrogen) and the assay protocol of Zhang et al. (10) . Briefly, 8 µM soluble Cdc42 was combined with 5 mM MgCl 2 , 0.2 mM GTP (Roche), 0.2 mM 2-amino-6-mercapto-7-methylpurine riboside (MESG), and 0.5 units of purine nucleoside phosphorylase (PNP) in 50 mM Hepes pH 7.5, 0.1 mM EDTA. Inorganic phosphate released by Cdc42 coupled to the MESG by the PNP to generate a product with an absorbance at 360 nM.
Absorbance readings were made using a SpectraMax Plus (Molecular Devices) reader. The addition of 1-4 nM of p50RhoGAP produced an increase in the rate of GTP hydrolysis (observed as a more rapid increase in absorbance).
N-WASP translocation to beads
Full-length Cdc42 WT and orthoCdc42, including the C-terminal CAAX motif, were expressed as His6- 
Nucleofection
The Cell Line 96-well Kit SE from Lonza Cologne AG was used to transfect the plasmids (all constructs are as listed in Table S4 
G-LISA assay
The Cdc42 G-LISA Kit (Cytoskeleton) was used to detect active GTP-bound Cdc42 in NIH 3T3 cells. 12-well culture plates were prepared by adding 1 mL of DMEM containing 10% BCS. After the nucleofection step, for each transfected sample, the cells were transferred to two prepared wells on the 12-well culture plates with 50 µL cells per well. After 8 h of culture followed by 7 h of starvation, for each transfected sample, Rapamycin in DMEM without serum was added to a final concentration of 20 µM to the cells in one well, and the other well served as the control by adding the same volume of DMSO as Rapamycin in DMEM without serum. Then, the medium was aspirated off at the indicated time points, and G-LISA Lysis Buffer was added to lyse the cells. The lysates were flash frozen in liquid nitrogen and stored at -70°C. The G-LISA assay was performed as specified as in the manufacturer's manual, after the lysates were diluted with G-LISA Lysis Buffer containing protease inhibitors to 0.7mg/mL total protein.
ELISA assay
To measure the total Cdc42 loaded for G-LISA assay, the wells of ELISA plates were first coated with
Chicken Polyclonal IgY Antibody to Cdc42 (AbCam). Then the cell lysates (same lysates as above) were added into the wells for Cdc42 binding, followed by adding an HRP-conjugated anti-Cdc42 monoclonal antibody (Santa Cruz Biotechnology) to Cdc42. TMB (3,3´,5,5´-tetramethylbenzidine) substrate solution was used for detection, and the absorbance at 450nm was measured after the addition of 1 M H 3 PO 4 to stop the reaction.
Live cell fluorescence microscopy
After the nucleofection step, NIH 3T3 cells were cultured in 8-well Lab-Tek II Chambered Coverglass wells. After the same serum starvation process as described above, pictures were taken on a Nikon
Eclipse Ti Microscope with a 60X or 100X objective at 37 °C. Rapamycin was added to a final concentration of 20 µM as above.
XCELLigence assay
The xCELLigence System (Roche Applied Science) can be used to monitor cell morphological changes in real time without the incorporation of labels. The electrode impedance, which is defined as cell index (CI)
values, is correlated with the change of cell morphology (11) . The xCELLigence system E-plate wells were coated with 40 µg/mL Fibronectin (Sigma-Aldrich) for 1 h at 37 °C. After washing with phosphatebuffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 , pH 7.4), the wells were blocked with 0.5% bovine serum albumin (BSA) solution in PBS for 20 min at 37 °C. 100 µL DMEM containing 10% BCS were added to each well after washing with PBS, and then the E-plates were equilibrated in an incubator (37 °C, 5% CO2). After the NIH 3T3 cells were transfected with indicated plasmids as described in the main Methods, 15 µL of transfected cells were transferred to each prepared E-plate well. The E-plates were then placed on the xCELLigence machine for real-time recording every 3 min. After eight hours, the medium in each well was changed to 100 µL of DMEM without serum for starvation. After 7 h of serum starvation, the data recording frequency was changed to 15 seconds and Rapamycin (Sigma-Aldrich) in DMEM without serum was added to each well to the final concentration of 20 µM.
Supplementary Results
Other designed ITSN variants using fixed and flexible backbone design Table S1 lists other predicted ITSN variants tested both in the context of Cdc42 WT and orthoCdc42. In addition to the ITSN S1373E variant, two other ITSN mutations were tolerated in the designed interface; the mutations were either predicted in sequences designed using flexible backbone simulations (M1369L)
or observed in several ITSN homologs and predicted to be favorable (L1376I). In contrast, the ITSN Q1380E mutation, which was the most frequently observed mutation in fixed backbone design simulations (Fig. 1D) , was not active towards orthoCdc42 (Fig. S2) when tested in combination with S1373E (which was present simultaneously, although much less frequently, in fixed backbone simulations). These results illustrate the difficulty in correctly predicting the precise details of polar interactions in protein interfaces, in particular when using fixed backbone approaches.
The L1376W substitution in ITSN, which was predicted in flexible backbone simulations to be favorable for the interaction with Cdc42 WT (Fig. S1C) , and also to be tolerated by orthoCdc42 (Fig. 1D) was not active in either context (Fig. S2) , possibly because of steric incompatibilities that result from overpacking.
Interactions with other GTPases and GTPase binding partners
The DH/PH domains of the exchange factor Dbs catalyze exchange in Cdc42 WT but not in orthoCdc42 (SI Table S3 ). One exchange factor, the DH domain of PREX1, is able to catalyze nucleotide exchange in both Cdc42 WT and orthoCdc42, whereas others, such as the DH/PH domains of the exchange factors Tiam1 and Trio (the N-terminal DH/PH) do not catalyze exchange in either Cdc42 WT or orthoCdc42 (SI Table S3 ). These results suggest that our design was successful in specifically perturbing the interaction with ITSN and the highly similar GEF Dbs.
Because ITSN is an exchange factor specific for Cdc42, ITSN does not catalyze nucleotide exchange in the Rac1 or RhoA GTPases, and orthoITSN does not change this intrinsic specificity (it does not catalyze exchange in either Rac1 or RhoA, SI Table S3 ).
Transferability of the designed mutations to a related GTPase/GEF interaction
Given the unique nature of the engineered complementary F56R/S1373E substitutions in the Cdc24/ITSN interface, we asked whether they could be transferred into another GTPase-GEF interface to make that interaction orthogonal with respect to the original wild-type binding partners and possibly other related GTPases and GEFs. However, simply porting the R-E pair to the structurally equivalent positions in the Rac1-Tiam1 interface was not successful in compensating for the detrimental effect of each of the mutations alone (SI Fig. S9 ). This result is not surprising, given the intricate nature of coupled residueresidue interactions in proteins and protein-protein interfaces. Interestingly, repeating our flexible backbone design prediction protocol as illustrated in Figure 1D on the crystal structure of the Rac1-Tiam1 complex corroborates this result and does not show enrichment for negatively charged amino acids at the Tiam1 position equivalent to 1373 in ITSN (SI Fig. S10 ).
Structural Analysis
The overall backbone Cα RMSD values between the orthoCdc42/orthoITSN and the Cdc42 WT /ITSN WT complex structure (PDB ID: 1KI1) are 0.58 Å and 0.47 Å for the Cdc42 molecules and the ITSN DH domains, respectively (SI Fig. S5A ). However, there are regions with larger deviations in the backbone, in particular the loop around Y40 in Cdc42, which rearranges to accommodate side chain movements triggered by the mutations, as discussed in the main manuscript (Fig. 3) . This region has a Cα RMSD of The designed complex structure has defined electron density in the active site of orthoCdc42 (SI Fig.   S5C ). In the course of refining the orthoCdc42/orthoITSN structure, this density persisted through simulated annealing omit and kicked map calculations. Based on the shape of the electron density, we binding. The active site residues of Cdc42 bound to ITSN would not clash directly with GDP. Rather, the direct clash of A59 with the Mg 2+ atom, which likely disfavors GDP binding, leads to higher GDP mobility and an increased probability of dissociation. The B-factors for the GDP molecule were higher than the surrounding protein atoms (~80 vs 54 for the protein). Since the resolution is not sufficient to refine occupancies or to observe any correlated structural changes in the protein, the simplest explanation is that the density represents a relatively disordered GDP molecule bound in the active site of orthoCdc42. In the Cdc42 WT /ITSN WT complex structure, an electron rich sulfate molecule is modeled in a position that overlaps with the placement of the beta-phosphate of the putative GDP (SI Fig. S5E ).
However, structure factors for this complex were not deposited, so electron maps cannot be calculated to determine if the density extends beyond the sulfate position. Currently we cannot distinguish whether the GDP molecule present in the orthoCdc42/orthoITSN is due to the engineered mutations, an intermediate conformation in nucleotide exchange, or would also be observed in the wild-type complex.
Flexible-backbone structure remodeling
To test whether the observed conformational changes in the orthoCdc42/orthoITSN interface could be computationally recapitulated, we implemented an initial version of a flexible backbone design and remodeling protocol intended to predict significant structural changes in response to designed mutations ( Figure S6A ). This protocol uses two general concepts: The first is switching between steps that diversify backbone conformations and steps that focus sampling in certain regions of conformational space. This idea has been used successfully in protein structure refinement (12) . Different backbone remodeling algorithms employing "backrub" (13) and "kinematic closure" (KIC) (14) moves allow us to diversify the conformations of the protein as well as to determine regions surrounding the designed positions that are particularly flexible and thus more likely to change upon mutation (12) . The second concept is interleaving soft and hard repulsive forces, which enables us to model conformational changes that initially appear unfavorable, but may be accommodated by subsequent refinement steps using intensified sampling in defined regions. Successful application of this concept has recently been reported in protein structure refinement (15) .
Modeling of the orthoCdc42/orthoITSN complex used the general protocol outlined in Figure S6A with the following steps and simulation details:
1. Design, soft potential: We introduced the two designed mutations, F56R and S1373E, into the template structure (PDB ID: 1KI1), keeping the backbone fixed and repacking the side chains in a 10 Å radius around the mutations. This step used the Rosetta all atom energy function with soft repulsive forces, which allow slightly unfavorable conformations of the side chains to still be accepted.
2. Initial backbone diversification, hard potential: Backbone diversification of the initial design model employed backrub moves (13) in a 10 Å radius around the mutations using the Rosetta all atom energy function with hard repulsive forces. This step generated an ensemble of 1200 structures with slight variations in the backbone that may accommodate the designed residues, while reducing possible steric clashes from the soft repulsive design step. The overall structural variation in this ensemble is low, however, and none of the structures is very close in backbone RMSD to the orthoCdc42/orthoITSN crystal structure ( Figure S6B ).
3. Aggressive backbone diversification, soft potential: To generate larger diversity, the next diversification step employed kinematic closure (KIC) refinement moves with soft repulsive forces.
Sampling was focused on two loop regions (36-44 in Cdc42 and 1365-1370 in ITSN) in a 10 Å radius of the mutated positions. To determine these focus regions in an unbiased fashion, we selected regions that showed the largest conformational variability in initial backbone diversification simulations of the template structure (PDB ID: 1KI1, Figure S6C ). This selection criterion follows the rationale described in (12) that regions with the largest simulated diversity in initial models are often the regions that show the largest deviation from the native structure. Figure S6D shows that many of the models resulting from the intense KIC backbone diversification step moved closer to the orthoCdc42/orthoITSN crystal structure. 4 . Intensification and refinement, hard potential. To intensify sampling around low-energy conformations identified in the previous step, the final simulation step employed KIC refinement moves in the same variable regions as in step (3) with hard repulsive forces using vicinity sampling, which restricts the sampled backbone angles to those similar to the input model. 600 input models were selected from the 10,000 decoys from step (3), using the following criteria: The 10,000 decoys were first binned by RMSD to the flexible regions in the template (so only information of the template structure was used, as in a general application the structure of the target, the designed complex, will not be known). Then, to represent the diversity of conformations sampled in step (3), we selected representative decoys from each bin such that the number of selected decoys scales logarithmically with the total number of structures in that bin, always choosing the lowest-energy decoys ( Figure S6E) . The intensification and refinement step adapts both backbone and side chains to remove clashes or unfavorable conformations that may have arisen in the preceding soft remodeling step. Application of KIC moves as well as repacking of the surrounding side chains and minimization of backbone and side chain torsion degrees of freedom resulted in considerably lower Rosetta energies ( Figure S6F , compare with Figure S6D ).
5.
Clustering. Figure S6F shows that, while conformations very close (< 1 Å backbone RMSD) to the crystal structure of the designed complex are sampled, they cannot be distinguished by energy from other sampled conformations. However, clustering the 2400 models resulting from step (4) by the Cα RMSD of the two flexible regions (between all pairs of models, again not considering information from the solved structure) clearly identifies a conformation close to the designed crystal structure for two of the six dominant clusters (Figures S6G, Fig. 3 in the main manuscript).
Cell-based assays
In all cell-based assays, we transiently transfected NIH 3T3 cells with combinations of plasmids encoding FKBP-ITSN, Cdc42 and Lyn-FRB, as indicated (Fig. 5 in the main manuscript) . ITSN and Cdc42 constructs were additionally tagged with fluorescent proteins (SI Table S4 ) to assess expression levels and localization. Prenylated Cdc42 is expected to be localized to the plasma membrane or bound to Rho-GDI. The ITSN-FKBP construct remained predominantly cytoplasmic until the addition of the small molecule Rapamycin.
We also measured induced morphological changes using the label-free xCELLigence system (Roche).
Cells transiently transfected with indicated plasmids adhere to E-plate wells covered with gold electrodes. Representation is as shown in Figure 1C in the main manuscript, but results are shown for all Cdc42 residues (instead of just Cdc42 residues in the interface with ITSN taken from PDB ID 1KI1). White blocks mean missing or non-interface residues.
(B) Application of fixed backbone computational second site suppressor design, as described in (1). F56
of Cdc42 was computationally mutated to all amino acids (except cysteine) and the effect on complex destabilization was computed (red bars, Δscore (destabilization) = score (complex 
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Figure S1 Shown is the temperature dependence of the circular dichroism signal (mean residue ellipticity, MRE) at 222 nm for Cdc42 (left) and ITSN (right). Because thermal melts are irreversible for both proteins, the curves cannot be interpreted in terms of equilibrium denaturation, but indicate similar onset of melting for wild-type (pink symbols) and engineered variants (black symbols). (C) Rho-GDI interaction. Cdc42 and RhoGDI form a stable complex and can be co-purified. Prenylated, His-tagged Cdc42 (the WT or F56R variant) were expressed in SF9 cells. GST-tagged RhoGDI was expressed in E. coli. SF9 and E. coli lysates were mixed and the Cdc42•RhoGDI complexes were purified using a Ni-NTA column followed by a GST-agarose column. Purified complexes were then run on an SDS-PAGE gel to verify that both the Cdc42 and RhoGDI proteins are present. (C) Cell retraction was observed as an additional phenotype under our experimental condition after the addition of Rapamycin. Flexible backbone computational design predictions (Methods) for the five residues in Tiam1 (H1178, E1183, S1184, I1187 and Q1191) close to position 56 of Rac1 for Rac1
WT (left) and Rac1* (W56R) (right). Simulations are as shown in Figure 1D in the main manuscript, except that the backbone of the crystal structure of Rac1/Tiam1 (PDB ID: 1FOE (16)) was used as the starting conformation to create a backrub ensemble. Position S1184 is not enriched for glutamate. 
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